Vaccines against HPV in people living with HIV: a review

• Published in: World cancer research journal Vol. 6
• Main Authors: F. D’Andrea, M. Ceccarelli, E. Venanzi Rullo, A. Facciolà, A. Marino, B. Cacopardo, G. Pellicanò, G. Nunnari
• Format: Journal Article
• Language: English
• Published: Verduci Editore 01-01-2019
• Subjects: adverse effects; cancer; efficacy; human immunodeficiency virus (hiv); human papilloma virus (hpv); safety; vaccination
• ISSN: 2372-3416
• DOI: 10.32113/wcrj_20197_1348

Human Papilloma Virus (HPV) infection represents the most common sexually transmitted infection worldwide. The best weapon to control the HPV infection is the primary prevention that includes interventions related to lifestyle and sexual habits and HPV-vaccination. HPV vaccination must be recommended not only for young girls, but also for boys, MSM and HIV-infected people. People Living with HIV (PLWHA) have high rates of persistent HPV infection if compared with HIV-uninfected people. Several data from HIV negative population have confirmed vaccine safety and efficacy, but there is limited data available on the efficacy of the vaccine among HIV-infected people. In this review, we considered the studies published about anti-HPV vaccination in PLWHA that we found performing a research on PUBMED (Bethesda, MD, USA) with the aim to point out the main aspects of vaccination in this particular population.